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Abstract
Background: In systems biology the experimentalist is presented with a selection of software for
analyzing dynamic properties of signaling networks. These tools either assume that the network is
in steady-state or require highly parameterized models of the network of interest. For biologists
interested in assessing how signal propagates through a network under specific conditions, the first
class of methods does not provide sufficiently detailed results and the second class requires models
which may not be easily and accurately constructed. A tool that is able to characterize the dynamics
of a signaling network using an unparameterized model of the network would allow biologists to
quickly obtain insights into a signaling network's behavior.
Results: We introduce PathwayOracle, an integrated suite of software tools for computationally
inferring and analyzing structural and dynamic properties of a signaling network. The feature which
differentiates PathwayOracle from other tools is a method that can predict the response of a
signaling network to various experimental conditions and stimuli using only the connectivity of the
signaling network. Thus signaling models are relatively easy to build. The method allows for tracking
signal flow in a network and comparison of signal flows under different experimental conditions. In
addition,  PathwayOracle  includes tools for the enumeration and visualization of coherent and
incoherent signaling paths between proteins, and for experimental analysis – loading and
superimposing experimental data, such as microarray intensities, on the network model.
Conclusion: PathwayOracle provides an integrated environment in which both structural and
dynamic analysis of a signaling network can be quickly conducted and visualized along side
experimental results. By using the signaling network connectivity, analyses and predictions can be
performed quickly using relatively easily constructed signaling network models. The application has
been developed in Python and is designed to be easily extensible by groups interested in adding
new or extending existing features. PathwayOracle is freely available for download and use.
Background
Reconstructing cellular signaling networks and under-
standing how they work are major endeavors in cell biol-
ogy. The scale and complexity of these networks, however,
render their analysis using experimental biology
approaches alone very challenging. As a result, computa-
tional methods have been developed and combined with
experimental biology approaches, producing powerful
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tools for the analysis of these networks. These tools aid
biologists in interpreting existing experimental findings,
evaluating hypotheses, enumerating possible biological
behaviors, and, ultimately, in quickly designing experi-
ments that maximize the amount of useful information
gained. By assisting biologists in maximizing the amount
of information obtained from their experiments through
improved experimental design and more thorough analy-
sis of results, computational tools increase the pace of sci-
entific discovery.
Biological network analysis can generally be classified as
either structural  or dynamic  [1]. Structural analysis pro-
vides insights into global properties of the network,
among them decomposition of the network into func-
tional modules (e.g., [2]), enumeration of signaling paths
connecting arbitrary protein pairs (e.g., [3-5]), and the
identification of key pathways that determine the behav-
ior of the network (e.g., [2,6-10]). Dynamic methods, on
the other hand, simulate the actual propagation of signals
through a network by predicting the changes in the con-
centration of signaling proteins over time. These predic-
tions will be of varying degrees of resolution and accuracy,
depending largely on the accuracy and level of detail of
the model from which they are produced.
The prevailing methods for dynamic analysis involve sys-
tems of ordinary differential equations (ODEs) [11,12].
These approaches require kinetic parameters for the indi-
vidual biochemical reactions involved in the signaling
process. This requirement often poses a significant hurdle
for researchers as the numerical values of such parameters
are difficult to obtain and may be the object of the
researcher's project in the first place. In [13], we presented
a novel signaling network simulation method which uses
a non-parametric Petri net model of network to predict
the signal flow under various experimental conditions.
Our simulation method uses a novel technique to approx-
imate the interaction speeds and predicts the qualitative
behavior of the signaling network dynamics.
The advantage of our method over ODEs is the wide avail-
ability of connectivity-based models of signaling net-
works, and the relative speed with which they can be
constructed. Numerous databases exist which catalog
known signaling interactions (e.g., [14-16]). Thus, the
existence and type (activating or inhibition) of an interac-
tion can often be inferred directly from literature and/or
these databases. This presents a stark contrast to the
kinetic parameters required by ODEs, the numerical val-
ues for many of which must be determined experimen-
tally for each experimental condition and cell line of
interest [2].
In this paper, we present the software tool PathwayOracle,
an integrated environment for connectivity-based struc-
tural and dynamic analysis of signaling networks, sup-
porting
• visualization of signaling network connectivity;
￿ two versions of the simulation method described in [13]
where
- the first allows prediction of signal flow through a given
network for a specific experimental condition, and
- the second predicts the difference in signal flow through
a given network induced by two different experimental
conditions;
￿ enumeration of the paths connecting arbitrary pairs of
nodes in the network; and
￿ visualization of experimental concentration data on the
signaling network display.
In future releases we plan on expanding capabilities in all
three areas of analysis – dynamic, structural, and experi-
mental – with a focus on providing effective ways of inte-
grating results from each together.
PathwayOracle has been designed in a modular fashion in
order to facilitate extension of existing capabilities and the
addition of new features.
Since PathwayOracle's most distinctive analytical capabil-
ity involves the signaling Petri net simulator, a new
dynamic analysis technique for signaling networks, we
first provide an overview of the signaling Petri net mode-
ling approach. Then in subsequent sections, we focus on
PathwayOracle and explain the architecture and core con-
cepts underlying the tool and then examine the individual
features, how they can be used, and how they compare to
existing tools.
The Signaling Petri Net Simulator
Petri nets provide a graphical and executable model of
processes in which information or material flows among
a series of places or entities [17]. A Petri net consists of
places, transitions, and tokens (see Figure 1). Quantities
of tokens are assigned to individual places. This assign-
ment is called a marking. As Figure 1 illustrates, the net-
work flow is modeled by the reassignment of tokens to
individual places in the Petri net in response to transition
firings.
A signaling Petri net is an extension of the Petri net for-
malism to model a signaling network. Places are signalingBMC Systems Biology 2008, 2:76 http://www.biomedcentral.com/1752-0509/2/76
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proteins and transitions implement directed protein inter-
actions; each transition models the effect of a source pro-
tein on a target protein. The marking of (number of
tokens in) protein p at time t is interpreted as the activity-
level of that protein – the number of activated molecules
of that type. Figure 2 shows the correspondence between
a signaling network and a signaling Petri net model.
The signaling Petri net simulator models signal flow as the
pattern of token accumulation and dissipation within
proteins over time in the Petri net. Through transition fir-
ings, the source can influence the marking of (the number
of tokens assigned to) the target, modeling the way that
signals propagate through protein interactions in cellular
signaling networks.
In order to overcome the issue of modeling reaction rates
in the network, signaling dynamics are simulated by exe-
cuting the signaling Petri net (SPN) for a set number of
steps (called a run) multiple times, each time beginning at
the same initial marking. For each run, the individual sig-
naling rates are simulated via generation of random
orders of transition firings (interaction occurrences).
When the results of a large enough number of runs are
averaged together, we find that the change in distribution
of tokens in the network correlate with experimentally
measured changes in the activity-levels of individual pro-
teins in the underlying signaling network. In essence, the
tokenized activity-levels computed by our method should
be taken as abstract quantities whose changes over time
correlate to changes that occur in the amounts of active
proteins present in the cell. It is worth noting that some of
the most widely used experimental techniques for protein
quantification – western blots and microarrays – also
yield results that are treated as indications, but not exact
measurements, of protein activity-levels within the cell.
Thus in some respects, the predictions returned by our
SPN-based simulator can be interpreted like the results of
a western blot or microarray experiment looking at
changes relative to "control".
During a simulation run, the simulator imposes a strict
ordering on transition firing such that it creates a two-time
scale simulation. The smaller time scale is discretized as
the firing of a single transition. This unit is referred to as
the firing time scale. Firing steps are nested within a larger
time scale, called time blocks, within which each transition
is fired exactly once. The values returned by the simulator
are the averaged token-counts for each protein at each
time-block (across all runs).
Figure 3 provides a small example of a simulation run
whose duration is two time blocks. As mentioned previ-
ously, within a given time block, each transition fires
exactly once. Thus, in the table (Figure 3(c)), there is one
column for each transition in each time block. The order-
ing of the transitions is shuffled in each time block in
order to sample a different set of signaling rates within the
networks.
In the first time block, transition t2 fires first: it reads 2
tokens out of Grb2 and places 2 additional tokens in Ras.
Transition t1 fires second, reading 3 tokens out of Grb2.
Transition t3 is evaluated last. The final marking for the
network, highlighted as the red column in block 1 is used
by the simulator as the marking for that block when aver-
aging across runs.
At the conclusion of block 2, compare the values high-
lighted in red in the Initial column and at the end of both
blocks. Note how the distribution of tokens have changed
over the course of the simulation. Grb2  has the same
number of tokens, implying that its activity-level has
remained unchanged – this is consistent with the signal-
ing network since no activating or inhibiting edges affect
it in the model. AKTs token-count has risen, consistent
with the fact that it is only activated in the signaling net-
work. Ras's token-count has fallen which is one plausible
behavior of the system since it is activated by Grb2, but
inhibited by AKT.
An example of how tokens move among places Figure 1
An example of how tokens move among places. In a 
Petri net, quantities of tokens are assigned to places. In (a), 
three tokens are assigned to place pA and zero tokens are 
assigned to place pB. The two places are connected by a tran-
sition, t1. The arcs in and out of t1 indicate the direction in 
which tokens move. When t1 fires, it moves some number of 
tokens from pA and puts them in pB. In (b), transition t1 has 
fired and moved two tokens from pA to pB.BMC Systems Biology 2008, 2:76 http://www.biomedcentral.com/1752-0509/2/76
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Implementation
PathwayOracle is written in Python [18]. The user experi-
ence is oriented around visualization of and interaction
with three main types of data: the signaling network,
markings, and paths. At any given time, one signaling net-
work is open, which is the basis for all analyses. Any sim-
ulation or concentration data is loaded and inspected as
markings. Currently all static analyses revolve around
paths, which are the third data type. In the following sub-
sections, these individual data types and the user inter-
faces to them are discussed in more detail.
The Signaling Network Model
While the implementation of our methods use the signal-
ing Petri net model discussed in an earlier section of this
paper, we provide a simpler and more convenient repre-
sentation of the network to the user which omits the inter-
nal topology of the transitions and allows the user to
specify interactions simply as either activating or inhibit-
ing. Thus, for the remainder of this paper we use the fol-
lowing definition of the signaling network which is
consistent with the experience the user will have when
working with PathwayOracle. The signaling network con-
nectivity is a directed graph G = (V, E) where
￿ V is the set of nodes, which are signaling proteins and
complexes (hereafter referred to collectively as signaling
nodes) and
￿ E is the set of edges, which are signaling interactions.
Each edge is of one of two types: u → v for activation and
u  v for inhibition.
Within PathwayOracle, each signaling node has a name,
unique within the network. A signaling edge has no prop-
erties besides its type and is only defined by its source and
target.
An example signaling network and its corresponding Petri net Figure 2
An example signaling network and its corresponding Petri net. An example signaling network (a) and its correspond-
ing Petri net (b). Each signaling protein in the network, A, B, and C, is designated as a place pA, pB, and pC. A signaling interaction 
becomes a transition node and its input and output arcs. Note that the connectivity for an activating edge differs from that of 
an inhibitory edge.BMC Systems Biology 2008, 2:76 http://www.biomedcentral.com/1752-0509/2/76
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An example signaling Petri net simulation Figure 3
An example signaling Petri net simulation. (a) is the signaling network being simulated. (b) is the signaling Petri net that 
models that signaling Petri net. The table in (c) provides the markings for the Petri net over the course of a simulation run 
whose duration is two time blocks. The proteins are given the initial marking shown in the Initial column. Each subsequent col-
umn corresponds to a single time step during which one transition fired, producing a new marking of the network. The bold 
number in each column indicates which protein's marking was affected by the transition that fired in that time step. The red 
columns – always the last time step in the block – highlight the markings whose values would be averaged and used as part of 
the final result. These red columns are the sources of the markings that PathwayOracle reports.BMC Systems Biology 2008, 2:76 http://www.biomedcentral.com/1752-0509/2/76
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In order to facilitate the rapid construction of such signal-
ing network models, we devised a file format called the
Connectivity Format. It is capable of expressing both gen-
eral networks as well as paths. When representing a net-
work in the format, as shown in the example in Figure
4(b), one signaling interaction is written on a line with
the format
u -> v or u - | v
where u is the name of the source signaling node and v is
the name of the target signaling node. Each node is taken
to represent the active form of the protein it is named for.
Thus, from the example above, the interaction PI-3-
K→AKT means that the active form of PI-3-K increases the
activity-level of AKT whereas the interaction PTENAKT
means that the active form of PTEN decreases the activity-
level of AKT. While these types of unparameterized rela-
tionships can be represented in SBML, SBML was designed
for encoding much more information than just connectiv-
ity [19]. As a result, we deemed it appropriate to design a
more concise format for our purposes. However, in a
future release, PathwayOracle  will support loading and
saving in the SBML format.
At a given point in time, only one signaling network can
be open in PathwayOracle. The main window displays a
graphical representation of the network. The layout of the
network can be modified by dragging nodes or by shift-
clicking on edges to create, remove, or move waypoints.
These layouts can be saved with the network and loaded
again.
Signaling Network Markings
In signaling networks, signal flow is measured and quan-
tified as the fluctuation of concentrations of various forms
of signaling proteins over time. In PathwayOracle, we
model concentrations using the concept of a network
marking, which was adapted from Petri nets in which it
was first used [9].
Markings
In PathwayOracle, a marking, μ is an assignment of real
values to the nodes of a signaling network such that every
signaling node receives a value. Earlier, the concept of a
marking was introduced as the assignment of tokens to
protein places in the signaling Petri net. In a signaling
Petri net, tokens are discrete. In PathwayOracle, a marking
is an average of the markings from many independent
simulation runs, which gives rise to the real, rather than
integral values, assigned by the marking.
As discussed earlier, the value of the marking of a signal-
ing node, μ(v), can be interpreted as an estimate of the
An example of a Network in the Connectivity Format Figure 4
An example of a Network in the Connectivity Format. (a) A graphical representation of a signaling network's connec-
tivity. (b) The signaling network in (a) written in the Network Connectivity Format.BMC Systems Biology 2008, 2:76 http://www.biomedcentral.com/1752-0509/2/76
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concentration or change in concentration of the active
form of the signaling protein v (we call the amount of the
active form of the signaling protein its activity-level). The
two different versions of the simulator generate markings
with these different meanings. The first simulator predicts
the signal flow due to an experimental condition and gen-
erates markings whose values are taken to represent the
actual activity-level of signaling protein present over the
assumed basal levels. The second version of the simulator
predicts the difference in signaling due to changing exper-
imental conditions. The values assigned by markings pro-
duced by this simulator correspond to the change in the
activity-level of the protein induced by the change in
experimental condition. This will be discussed further in
the Results and Discussion section.
Marking Series
In order to model signal flow, a single marking is not
enough since it only provides a single snapshot of concen-
trations throughout the network. A marking series is an
sequence of markings, (μ1, μ2,..., μT) in which the marking
μt is a snapshot of the concentration distribution at time
step t. Thus, it is possible to see how the activity-level of
protein v changed by plotting the values μ1(v), μ2(v),...,
μT(v). PathwayOracle provides the ability to do this.
PathwayOracle supports loading a marking series dataset
from comma-separated value (.csv) files. As shown in Figure
5(a), the file has a header row which specifies, for each
column, the name of the molecule whose concentration
values will appear in that column. Each subsequent row
contains the value assignments for a marking: the second
row contains the marking for time step 1, the third row
contains the marking for time step 2, and so on.
Marking Groups
In many experiments, the activity-level of various proteins
are sampled at different time points and under different
experimental conditions. Since the marking series is not
able to represent changes due to different experimental
conditions, we introduced the more general concept of a
marking group in which each marking can correspond to
an arbitrary activity-level distribution. Each marking is
given a descriptive label that can be used to identify the
conditions under which the activity-level was sampled.
Like the marking series, a marking group is loaded from a
.csv file. However, unlike the marking series in which each
row corresponds to a time step, in the marking group,
each row corresponds to an independent marking (exper-
imental condition). As shown in Figure 5(b), the first row
is a header row specifying the molecule names for each
column, the first column specifies the names for the indi-
vidual markings (experimental conditions).
The Marking Manager
PathwayOracle includes a specific user-interface, the Mark-
ing Manager, designed to manage the three different types
of markings. The Marking Manager provides a central
interface within which it is possible to view all markings
loaded and inspect them in ways that are relevant to their
type (marking, marking series, or marking group). The
specific ways in which markings can be inspected will be
discussed further in the Results section.
Signaling Paths
The current structural analysis capabilities available in
PathwayOracle allow inspection of signaling paths within
the network. A signaling path p is a sequence of nodes, (v1,
v2,..., vk) where vi ∈ V ∀1 ≤ i ≤ k, and (vi, vi + 1) ∈ E ∀1 ≤ i
<k. In this case, we say that node v1 is the source of path
p, and node vk is the target of p. Given a path, a variety of
statistics may be of interest to the user. Additionally, it
may be useful to view the path within the larger network.
PathwayOracle  provides these capabilites which will be
discussed in the Results and Discussion section.
Examples of marking series and group file formats Figure 5
Examples of marking series and group file formats. (a) An example marking series dataset in the comma-separated value 
file format. The first row specifies the signaling proteins whose concentrations were measured. Each row thereafter specifies 
the concentration for a given time step: row i specifies the concentrations for each signaling protein at time step i - 1. (b) An 
example marking group dataset in the comma-separated value file format. The first row specifies the signaling proteins whose 
concentrations were measured. The first column specifies the names for each marking in the group dataset. The numbers in 
each row specify the concentration measured for each signaling protein in that marking.BMC Systems Biology 2008, 2:76 http://www.biomedcentral.com/1752-0509/2/76
Page 8 of 14
(page number not for citation purposes)
Sets of paths can be saved to a file and loaded back into a
session. Like networks, paths are also stored in the Con-
nectivity Format. When representing a set of paths, as
shown in Figure 6, the full node names and the edge types
are written so that all path information is directly availa-
ble within the file itself. One line contains one path.
Results
PathwayOracle provides a variety of tools for analyzing the
structural and dynamic properties of a signaling network
based on its connectivity. While its main differentiating
feature is the ability to predict signal flow through a net-
work using only the connectivity of the signaling network,
PathwayOracle also provides the ability to visualize the
network, analyze its connectivity, and inspect concentra-
tion-based experimental data.
With the exception of the signaling Petri net simulator,
PathwayOracle's features can be found in various combi-
nations in other tools. Figure 7 provides a matrix of the
features and capabilities of several tools most commonly-
used for signaling network analysis. While other tools
support a variety of simulation techniques, PathwayOra-
cle, alone, provides non-parameterized simulation capa-
bilities. It is worth noting that the commercial software
package CellIllustrator [20] provides Petri net-based sim-
ulation capabilities. The difference between CellIllustrator
and PathwayOracle Petri net approaches is the extensive
set of kinetic parameters required by CellIllustrator in
order to simulate a biological system. In this regard,
hybrid functional Petri nets, the underlying technology
used by CellIllustrator, are not significantly different from
ODEs.
Another important distinguishing characteristic of Path-
wayOracle is the combination of features that it supports.
Biological network analysis is a multi-faceted process that
may involve structural, dynamic, and data analysis in par-
allel. Whereas other tools tend to focus on one or two of
these general areas of analysis, we considered it important
for PathwayOracle to incorporate all three in order to pro-
vide the researcher a single environment in which all their
analysis could be done. In future releases we plan to
increase PathwayOracle's support for all three of these
directions of investigation: structural, dynamic, and data
analysis.
In the remainder of this section, we discuss the features
currently available in PathwayOracle.
Network Visualization
As in many other computational analysis tools for signal-
ing networks (e.g., [20,21]), an interactive graphical rep-
resentation of the signaling network connectivity is at the
center of the PathwayOracle interface. The main window
provides a visualization of the signaling network connec-
tivity. This visualization interface allows the user to edit
the layout of the network by clicking on and dragging
nodes and by shift-clicking on edges to create, remove, or
move waypoints. Waypoints are points that lie on an
edge. Holding down shift will display all edge waypoints.
Existing waypoints can be dragged to change the path that
an edge follows. Right-clicking on a waypoint will remove
it. Left-clicking on a straight segment of the edge will cre-
ate a new waypoint.
The network visualization also provides a view onto
which path and experimental data analysis may be
mapped. As will be discussed in subsequent sections,
selected paths may be highlighted in this view and mark-
ings from experiments can set the colorings of individual
nodes.
Network Signal Flow Simulation
The main feature differentiating PathwayOracle from other
tools, such as CellDesigner [20] and COPASI [22], is its
ability to simulate signal flow using an unparameterized
signaling network model. Simulations can be performed
in two different ways. In the first (Single Simulation), the
simulator predicts the signal flow through the network for
a specific experimental condition. In the second (Differen-
tial Simulation), the simulator predicts the difference in
An example of a Path in the Connectivity Format Figure 6
An example of a Path in the Connectivity Format. (a) A graphical representation of two signaling paths. (b) The signal-
ing paths in (a) represented in the Connectivity Format. Each line corresponds to a single signaling path.BMC Systems Biology 2008, 2:76 http://www.biomedcentral.com/1752-0509/2/76
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signal flow due to two different experimental conditions
on the same network. These simulation methods them-
selves are described in [13]. Here we focus on how simu-
lations are configured, run, and analyzed.
Whereas the consensus networks typically represent the
connectivity in normal cells, many experiments are con-
ducted on abnormal cells in which oncogenic mutations,
gene knockous, and pharmacological inhibitors have
altered the behavior of various signaling nodes in the net-
work. In PathwayOracle users can model these cell- and
experiment-specific conditions by specifying each signal-
ing node as either High, Low, or Free. The High state mod-
els any condition under which a protein's activity-level is
held high for the duration of the experiment. This may be
due to external stimulation or a known mutation in the
protein that makes it constitutively active, for example.
Similarly, a Low state models any phenomenon that forces
a protein to have a persistently suppressed activity-level.
This may be due to mutations that render the protein inac-
tive, gene knockouts, or pharmacological inhibitors that
force the activity-level of the protein low. In general, most
signaling nodes will be Free, which means that their activ-
ity-level is unconstrained throughout the simulation.
Only those nodes designated as High or Low will have
their activity-level fixed for the duration of the simulation.
In order for a protein to be held high during the simula-
tion, it is necessary to indicate the initial activity-level that
the protein will be elevated to. This is done by specifying
the number of tokens that the protein will receive. Since a
protein with a High  state cannot be inhibited (even if
inhibitory edges target it in the actual network), the pro-
tein's activity level will never fall below this initial value.
The initial value for a High protein is indicated by placing
it in parentheses next to the protein's name, as shown in
Figure 8. Two other parameters that must be specified for
a simulation are:
￿ the number of simulation runs to perform and
￿ the number of time blocks
The number of runs sets the number of independent sim-
ulations whose time block markings are averaged together
to yield the overall simulation markings. In general, using
more runs is a tradeoff between reliability of the results
and simulation speed. In practice, the number of runs
needed is dependent on the signaling network model and
should be selected by observing the reproducability of the
simulation results. An appropriate number of iterations
will be large enough so that for a given experimental con-
dition, the results are very similar across multiple simula-
tions.
The time block, as discussed earlier, is a fundamental unit
of time in the simulator. The appropriate number of time
blocks for which to simulate will vary depending on the
size of the signaling network and the scale of the network
behavior of interest. Generally it should be selected by
running simulations for a variety of time block values and
determining which yields the most biologically reasona-
ble activity-level changes for a known protein. While this
is a manual process in the current version of PathwayOra-
cle, we are investigating automated methods for estimat-
A comparison of features supported by tools commonly used for signaling network analysis Figure 7
A comparison of features supported by tools commonly used for signaling network analysis. The table shows the 
features and analytical capabilities supported by different tools commonly used for the analysis of signaling networks. Tools 
included in the comparison are: CellDesigner [20], CellIllustrator [24], CellNetAnalyze [25], COPASI [22], Cytoscape [21], the 
System Biology Toolkit for Matlab [26], and PathwayOracle.BMC Systems Biology 2008, 2:76 http://www.biomedcentral.com/1752-0509/2/76
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The tokenized simulator user interface Figure 8
The tokenized simulator user interface. (a) The setup window for the tokenized simulator. The simulation is being con-
figured to have two High nodes, EGF and LKB-auto. EGF will be initialized with a token-count of 10, LKB-auto with a token-
count of 3. The token-count of AMPK will be zero for the duration of the simulation. (b) The setup window for the differential 
simulator. Two different scenarios are being compared through simulation: different token assignments are being tried with 
EGF and LKB-auto, with and without AMPK being fixed low. (c) The plot window for the marking series generated by a simu-
lation. Observe that the signaling nodes whose activity-levels are plotted correspond to those selected in the checklist directly 
to the left of the plot.BMC Systems Biology 2008, 2:76 http://www.biomedcentral.com/1752-0509/2/76
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ing the number of time blocks by training against
experimental time series data.
In PathwayOracle, the setup window for the Single Simula-
tion (see Figure 8(a)) prompts the user for a single experi-
mental condition. The setup window for the Differential
Simulation  (see Figure 8(b)) prompts the user for two
experimental conditions. Both simulators produce a
marking series. The tokenized simulation marking series
corresponds to the activity-level time series predicted for
the specified experimental condition. The differential sim-
ulation marking series corresponds to the change in activ-
ity-levels over time produced by switching from
experimental condition 2 to experimental condition 1.
The marking series produced by a simulation can be
accessed through the Marking Manager. Choosing to
inspect a marking series will present the user with a blank
plot. By selecting signaling nodes, the plot is populated by
the marking series values for individual nodes over time,
as shown in Figure 8(c).
While this plot generation capability exists in many other
dynamic simulation tools, the simplicity of the model
used for simulation and the speed with which a simula-
tion runs set PathwayOracle apart from other tools which
require specification of the numerical values of kinetic
parameters for each reaction in the network of interest
(e.g., [20,22]). PathwayOracle, because of its novel
approach, does not have such requirements. It is worth
noting, however, where PathwayOracle provides approxi-
mations of signal flow, an ODE generates the actual con-
centration changes using extremely detailed and accurate
models of the underlying biochemistry. The simulators in
PathwayOracle provide an attractive, time- and resource-
saving alternative this more exhaustively parameterized
techniques. In particular, PathwayOracle's  features will
benefit researchers interested in quickly assessing charac-
teristics of signal flow in their network.
For some networks, biologists will have partial knowledge
of kinetic parameters or of other biological details which
the signaling Petri net model does not, at present, con-
sider. By integrating this knowledge into the simulator, it
may be possible to improve the simulator's predictions.
We identify this as a direction for future investigation. As
the signaling Petri net simulator is extended, these new
capabilities will be incorporated in future releases of Path-
wayOracle.
Signaling Path Analysis
The use of the simulators and plotting tools allows the
user to observe trends in the activity-level of individual
signaling nodes over time. Since the activity-level of a
node is determined by the activity-level of other nodes in
the network, the activity-level time series of a node may be
explained by changes in the activity-level history of nodes
upstream of it. In order to investigate such indirect inter-
actions, it is useful to enumerate all the paths leading
from a specific protein to the protein of interest. Pathway-
Oracle provides this capability. Additionally, it provides
various statistics on the set of paths linking two signaling
nodes as well as a classification of the effect of each path
as either coherent or incoherent (e.g. [23]). A coherent path
is a directed series of interactions that leads from x to y
such that an increase in the activity-level of x causes an
increase in the activity of y and a decrease in the activity-
level of x causes a decrease in the activity-level of y. An
incoherent path is a directed series of interactions leading
from x to y such that an increase in the activity-level of x
causes a decrease in the activity-level of y and a decrease in
the activity-level of x causes a increase in the activity-level
of y. It is possible to classify a path p as either coherent or
incoherent by counting the number of inhibitory edges
along p. A path with an even number of inhibitory edges is
coherent; a path with an odd number of inhibitory edges is inco-
herent [5]. This logic is assumed in PathwayOracle. All sim-
ple paths (paths without loops) connecting two specified
signaling nodes are enumerated by an exhaustive depth-
first search. These paths then are classified as either coher-
ent or incoherent, and presented to the user for further
inspection in a window similar to the one shown in Figure
9(a). When a path is selected in the results window, it is
highlighted in the main window, allowing the user to
evaluate it within the context of the complete network
(see Figure 9(b)).
Experimental Data Analysis
A model of the connectivity of a signaling network makes
it possible to identify components of the model that are
inconsistent with experimental data or visa versa. Path-
wayOracle enables this kind of analysis by allowing users
to load experimental concentration data and visualize it
both as a heatmap (see Figure 10(a)) or superimposed on
the network view (see Figure 10(b)). Several other soft-
ware tools provide similar capabilities (e.g., [21]). In Path-
wayOracle, experimental concentration data is loaded as a
marking group in which a single marking corresponds to
a condition for which concentrations were sampled. Fig-
ure 10(a) shows a marking group with 24 conditions
(rows). The concentration of seven signaling proteins
were sampled for each condition. This is the heatmap
view for the marking group. When a specific marking in
the group is selected, the colors for that marking are
applied to the network view. This is particularly useful
when assessing whether the experimental data is consist-
ent with the interactions in the model. In Figure 10, the
MDA231-B-DMSO2 marking has been superimposed on
the network. We can see that RSK has a relatively low con-
centration despite the high concentration of MAPK. Given
that, in the model, RSK is activated by MAPK, this combi-BMC Systems Biology 2008, 2:76 http://www.biomedcentral.com/1752-0509/2/76
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nation of activity-levels seems unlikely to occur. Such an
inconsistency suggests that there may be other signaling
interactions contributing to the overall activity-level of
RSK. Such an insight can help a researcher quickly identify
areas where the model or experimental results need to be
re-evaluated or improved.
Future Directions
Our goal is to develop PathwayOracle into an integrated
and expansive suite of tools that allow the biologist to
extract as much information as possible from models of
signaling network connectivity and experimental data
relating to those models. We consider future directions for
PathwayOracle to fall into several categories: network con-
struction, network augmentation, experimental and com-
putational analysis integration, and architecture.
One of the benefits of working with connectivity models
of signaling networks is the abundance of databases and
other online resources that publish connectivity-level
data. Future versions of PathwayOracle will have support
for querying such databases for connectivity components
and, ultimately, for automated connectivity construction
based on a set of signaling nodes specified by the user.
Analysis of network connectivity and topology is increas-
ingly relevant to biological research. We intend to expand
PathwayOracle's structural analysis features to include the
ability to search for and identify motifs in the signaling
networks.
Network connectivity can also be inferred from experi-
mental data, which provides another direction for
research and development. By using experimental results
to identify inconsistencies between experimental results
and the current network model, it may be possible for
PathwayOracle to augment the network with new connec-
tivity based on hints supplied by experimental results. At
present only experimental concentration data is sup-
ported. However, as experiments produce more informa-
tion beyond concentration profiles of signaling nodes, we
plan to expand the experimental data that PathwayOracle
can load, visualize, and use as part of network analyses.
Experimental results can also provide computational
analysis methods information that can improve their final
predictions or decompositions. Taking advantage of the
additional, potentially obfuscated, information present in
experimental results to improve the results returned by
computational tools is a major goal for future versions of
PathwayOracle.
The path interrogation user interface Figure 9
The path interrogation user interface. (a) The result window enumerating the set of all paths between Ras and mTOR/rap-
tor. (b) The main network view showing the selected path highlighted.BMC Systems Biology 2008, 2:76 http://www.biomedcentral.com/1752-0509/2/76
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A longer term direction for PathwayOracle is the integra-
tion of transcriptional and metabolic network analysis. In
the biological systems of interest, the behavior of any one
of these networks is dependent on the characteristics of
the other two. As a result, developing a complete under-
standing of signaling, transcriptional regulation, or
metabolism depends in part on integrating knowledge
from the others. Finally, an ongoing priority in the design
of PathwayOracle is its role as an open platform for the
development and deployment of new analytical capabili-
ties by other groups. Currently PathwayOracle employes a
modular architecture that facilitates easy integration of
new functionality. However, in future releases we plan to
expose a plugin interface which will make it easier to
developers and researchers to develop and deploy tools
within PathwayOracle.
Conclusion
PathwayOracle is an integrated software environment in
which biologists may conduct structural and dynamic
analysis of signaling networks of interest. PathwayOracle is
distinguished from other tools in the field of systems biol-
ogy by its ability to predict the signal flow through a net-
work using a simplified, connectivity-based model of the
signaling network. Simulations are fast and, based on a
published study, predictors of signal propagation. This
novel simulation capability, combined with support for
structural analysis of connectivity between pairs of pro-
teins and for analysis of certain kinds of experimental data
make PathwayOracle a powerful asset in the experimental-
ist's endeavor to gain a more complete understanding of
the cellular signaling network.
The marking group user interface Figure 10
The marking group user interface. (a) The heat map visualization of a marking group. The selected marking, MDA231-B-
DMSO1, is highlighted in blue. (b) The color distribution for the selected marking in the group is applied to the network view 
in the main window. Note that signaling nodes for which values were not given are not assigned a color on the valid red to 
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Availability and requirements
Project name: PathwayOracle
Project home page: http://bioinfo.cs.rice.edu/pathwayor
acle
Operating system(s): Platform independent
Programming language: Python
Other requirements: Python 2.4 or higher
License: GNU GPL
Any restrictions to use by non-academics: None
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